Posted Mar. 13, 2012 at 1:03 p.m.

Premium Lock Raleigh-based Salix Pharmaceuticals to raise $600M

Published: 2012-03-13 13:03:45
Updated: 2012-03-13 13:03:45

Print this blog post
Salix Salix

Salix says it will repurchase outstanding convertible senior notes that are due in 2028. The company also plans to repurchase up to $75 million of its outstanding common stock and will also use proceeds for corporate purposes....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll